Ansell Cap Corp (ANCCF) 0.2180 $ANCCF
BriaCell Therapeutics Begins Trading on the OTCQB (ANCCF) and Presents at a New York Biotech Investor Conference
Marketwired - Wed Jun 24, 8:30AM CDT
BriaCell Therapeutics Corp (TSX VENTURE: BCT) (OTCQB: ANCCF) ("BriaCell", the "Company", or "BCT"
, a clinical stage cancer immunotherapy company, has been approved to begin trading today on the OTCQB® Marketplace in the United States under the symbol "ANCCF". The Company will continue to trade on the Toronto Stock Exchange Venture under the symbol "BCT".
BCT.VN: 0.260 (unch)
BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and Royalty Relinquishment Corporate Update
GlobeNewswire - Wed Dec 03, 11:26AM CST
BriaCell Therapeutics Corp (TSX-V:BCT) ("BriaCell", the "Company", or "BCT" is pleased to announce that it has, effective December 1, 2014, completed its Go-Public Event onto the Toronto Stock Exchange Venture (the "Go-Public" and concurrent financing (the "Financing" (together referred to as the "Transaction" with Ansell Capital Corp ("Ansell". The Company's shares are now trading under the symbol BCT. The terms of the Go-Public Event, which was structured as a Reverse Takeover ("RTO" under the rules and policies of the TSX Venture Exchange (the "TSX-V", were previously announced by the Company in a release dated April 17, 2014. The Transaction was approved by 100.00% of shareholders. At a deemed value of $0.18 the Company's market value is approximately $15 million.
BCT.VN: 0.260 (unch)
IIROC Trading Resumption - BCT
CNW Group - Tue Dec 02, 3:12PM CST
Trading resumes in:
BriaCell Therapeutics Begins Trading on the OTCQB (ANCCF) and Presents at a New York Biotech Investor Conference
Marketwired - Wed Jun 24, 8:30AM CDT
BriaCell Therapeutics Corp (TSX VENTURE: BCT) (OTCQB: ANCCF) ("BriaCell", the "Company", or "BCT"
, a clinical stage cancer immunotherapy company, has been approved to begin trading today on the OTCQB® Marketplace in the United States under the symbol "ANCCF". The Company will continue to trade on the Toronto Stock Exchange Venture under the symbol "BCT". BCT.VN: 0.260 (unch)
BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and Royalty Relinquishment Corporate Update
GlobeNewswire - Wed Dec 03, 11:26AM CST
BriaCell Therapeutics Corp (TSX-V:BCT) ("BriaCell", the "Company", or "BCT"
is pleased to announce that it has, effective December 1, 2014, completed its Go-Public Event onto the Toronto Stock Exchange Venture (the "Go-Public" and concurrent financing (the "Financing" (together referred to as the "Transaction" with Ansell Capital Corp ("Ansell". The Company's shares are now trading under the symbol BCT. The terms of the Go-Public Event, which was structured as a Reverse Takeover ("RTO" under the rules and policies of the TSX Venture Exchange (the "TSX-V", were previously announced by the Company in a release dated April 17, 2014. The Transaction was approved by 100.00% of shareholders. At a deemed value of $0.18 the Company's market value is approximately $15 million. BCT.VN: 0.260 (unch)
IIROC Trading Resumption - BCT
CNW Group - Tue Dec 02, 3:12PM CST
Trading resumes in:
